Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
AVAILABLE
NCT04710056
Compassionate Use or Expanded Access of Mibavademab
Sponsor: Regeneron Pharmaceuticals
View on ClinicalTrials.gov
Summary
Provide Expanded Access to REGN4461 for patients with diseases associated with deficient leptin signaling.
Key Details
Gender
All
Age Range
Any - Any
Study Type
EXPANDED_ACCESS
Enrollment
Not specified
Start Date
Not specified
Completion Date
Not specified
Last Updated
2026-10-27
Healthy Volunteers
Not specified
Interventions
DRUG
REGN4461
To be provided by Regeneron